GO:0006139 | nucleobase-containing compound metabolic process | 26.32% (15/57) | 3.01 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 26.32% (15/57) | 2.81 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 22.81% (13/57) | 3.14 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 26.32% (15/57) | 2.84 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 26.32% (15/57) | 2.88 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 26.32% (15/57) | 2.56 | 0.0 | 1e-06 |
GO:0006974 | DNA damage response | 12.28% (7/57) | 4.43 | 0.0 | 2e-06 |
GO:0033554 | cellular response to stress | 12.28% (7/57) | 4.26 | 0.0 | 3e-06 |
GO:0051716 | cellular response to stimulus | 12.28% (7/57) | 4.2 | 0.0 | 4e-06 |
GO:0009987 | cellular process | 42.11% (24/57) | 1.32 | 6e-06 | 0.000189 |
GO:0006259 | DNA metabolic process | 10.53% (6/57) | 3.67 | 8e-06 | 0.000224 |
GO:0006807 | nitrogen compound metabolic process | 35.09% (20/57) | 1.47 | 1.1e-05 | 0.000252 |
GO:0042770 | signal transduction in response to DNA damage | 3.51% (2/57) | 8.53 | 1.1e-05 | 0.000256 |
GO:0000077 | DNA damage checkpoint signaling | 3.51% (2/57) | 8.53 | 1.1e-05 | 0.000256 |
GO:0006281 | DNA repair | 8.77% (5/57) | 4.0 | 1.6e-05 | 0.00033 |
GO:0031570 | DNA integrity checkpoint signaling | 3.51% (2/57) | 7.95 | 2.7e-05 | 0.000519 |
GO:0003676 | nucleic acid binding | 22.81% (13/57) | 1.81 | 5.9e-05 | 0.001085 |
GO:0016070 | RNA metabolic process | 12.28% (7/57) | 2.79 | 6.5e-05 | 0.00112 |
GO:0044237 | cellular metabolic process | 29.82% (17/57) | 1.43 | 9.8e-05 | 0.001603 |
GO:0003677 | DNA binding | 15.79% (9/57) | 2.25 | 0.000105 | 0.001623 |
GO:0010948 | negative regulation of cell cycle process | 3.51% (2/57) | 6.83 | 0.000139 | 0.001718 |
GO:0000075 | cell cycle checkpoint signaling | 3.51% (2/57) | 6.83 | 0.000139 | 0.001718 |
GO:1901988 | negative regulation of cell cycle phase transition | 3.51% (2/57) | 6.83 | 0.000139 | 0.001718 |
GO:0043170 | macromolecule metabolic process | 29.82% (17/57) | 1.4 | 0.000127 | 0.001795 |
GO:0005488 | binding | 50.88% (29/57) | 0.9 | 0.000125 | 0.001851 |
GO:1901987 | regulation of cell cycle phase transition | 3.51% (2/57) | 6.36 | 0.000271 | 0.003226 |
GO:0045786 | negative regulation of cell cycle | 3.51% (2/57) | 6.28 | 0.000302 | 0.003469 |
GO:0006302 | double-strand break repair | 3.51% (2/57) | 6.21 | 0.000335 | 0.003714 |
GO:0044238 | primary metabolic process | 33.33% (19/57) | 1.16 | 0.000396 | 0.004229 |
GO:0008152 | metabolic process | 35.09% (20/57) | 1.04 | 0.000804 | 0.008304 |
GO:0071704 | organic substance metabolic process | 33.33% (19/57) | 1.06 | 0.001001 | 0.009696 |
GO:0006950 | response to stress | 12.28% (7/57) | 2.15 | 0.000974 | 0.009736 |
GO:0019136 | deoxynucleoside kinase activity | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0030289 | protein phosphatase 4 complex | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0004797 | thymidine kinase activity | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0000012 | single strand break repair | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0000737 | obsolete DNA catabolic process, endonucleolytic | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0034508 | centromere complex assembly | 1.75% (1/57) | 9.53 | 0.001351 | 0.010471 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 7.02% (4/57) | 3.09 | 0.001274 | 0.011965 |
GO:0043226 | organelle | 10.53% (6/57) | 2.22 | 0.001762 | 0.013004 |
GO:0043229 | intracellular organelle | 10.53% (6/57) | 2.22 | 0.001762 | 0.013004 |
GO:0005634 | nucleus | 7.02% (4/57) | 2.94 | 0.001859 | 0.0131 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 8.77% (5/57) | 2.51 | 0.001849 | 0.013332 |
GO:0046049 | UMP metabolic process | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0008821 | crossover junction DNA endonuclease activity | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0006222 | UMP biosynthetic process | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0004588 | orotate phosphoribosyltransferase activity | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0016889 | DNA endonuclease activity, producing 3'-phosphomonoesters | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0009173 | pyrimidine ribonucleoside monophosphate metabolic process | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0030896 | checkpoint clamp complex | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0009174 | pyrimidine ribonucleoside monophosphate biosynthetic process | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 1.75% (1/57) | 8.53 | 0.0027 | 0.013723 |
GO:0008150 | biological_process | 47.37% (27/57) | 0.71 | 0.002366 | 0.014669 |
GO:0097159 | organic cyclic compound binding | 31.58% (18/57) | 1.0 | 0.002158 | 0.014864 |
GO:0050896 | response to stimulus | 12.28% (7/57) | 1.92 | 0.002366 | 0.014967 |
GO:0018130 | heterocycle biosynthetic process | 7.02% (4/57) | 2.74 | 0.003054 | 0.015028 |
GO:0019438 | aromatic compound biosynthetic process | 7.02% (4/57) | 2.74 | 0.003029 | 0.015147 |
GO:0016570 | histone modification | 3.51% (2/57) | 4.8 | 0.002364 | 0.01527 |
GO:0005575 | cellular_component | 21.05% (12/57) | 1.34 | 0.002269 | 0.015294 |
GO:0032774 | RNA biosynthetic process | 5.26% (3/57) | 3.52 | 0.002334 | 0.015392 |
GO:0140097 | catalytic activity, acting on DNA | 5.26% (3/57) | 3.47 | 0.00258 | 0.015681 |
GO:0010564 | regulation of cell cycle process | 3.51% (2/57) | 4.55 | 0.003322 | 0.016091 |
GO:0043933 | protein-containing complex organization | 5.26% (3/57) | 3.32 | 0.003412 | 0.016272 |
GO:0009532 | plastid stroma | 1.75% (1/57) | 7.95 | 0.004048 | 0.018186 |
GO:0009570 | chloroplast stroma | 1.75% (1/57) | 7.95 | 0.004048 | 0.018186 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.75% (1/57) | 7.95 | 0.004048 | 0.018186 |
GO:0019206 | nucleoside kinase activity | 1.75% (1/57) | 7.95 | 0.004048 | 0.018186 |
GO:1901362 | organic cyclic compound biosynthetic process | 7.02% (4/57) | 2.6 | 0.004275 | 0.018931 |
GO:0071824 | protein-DNA complex organization | 3.51% (2/57) | 4.19 | 0.005426 | 0.021293 |
GO:0000776 | kinetochore | 1.75% (1/57) | 7.53 | 0.005393 | 0.021436 |
GO:0016149 | translation release factor activity, codon specific | 1.75% (1/57) | 7.53 | 0.005393 | 0.021436 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.75% (1/57) | 7.53 | 0.005393 | 0.021436 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 1.75% (1/57) | 7.53 | 0.005393 | 0.021436 |
GO:0016151 | nickel cation binding | 1.75% (1/57) | 7.53 | 0.005393 | 0.021436 |
GO:0043231 | intracellular membrane-bounded organelle | 7.02% (4/57) | 2.53 | 0.005168 | 0.021945 |
GO:0043227 | membrane-bounded organelle | 7.02% (4/57) | 2.53 | 0.005168 | 0.021945 |
GO:0006260 | DNA replication | 3.51% (2/57) | 4.25 | 0.005042 | 0.022016 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 1.75% (1/57) | 7.21 | 0.006737 | 0.024572 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 1.75% (1/57) | 7.21 | 0.006737 | 0.024572 |
GO:0016593 | Cdc73/Paf1 complex | 1.75% (1/57) | 7.21 | 0.006737 | 0.024572 |
GO:0043087 | regulation of GTPase activity | 1.75% (1/57) | 7.21 | 0.006737 | 0.024572 |
GO:0030176 | obsolete integral component of endoplasmic reticulum membrane | 1.75% (1/57) | 7.21 | 0.006737 | 0.024572 |
GO:0051726 | regulation of cell cycle | 3.51% (2/57) | 4.06 | 0.006513 | 0.025239 |
GO:0110165 | cellular anatomical entity | 15.79% (9/57) | 1.36 | 0.00772 | 0.027827 |
GO:0008237 | metallopeptidase activity | 3.51% (2/57) | 3.92 | 0.007844 | 0.027951 |
GO:0036297 | interstrand cross-link repair | 1.75% (1/57) | 6.95 | 0.00808 | 0.028142 |
GO:0004520 | DNA endonuclease activity | 1.75% (1/57) | 6.95 | 0.00808 | 0.028142 |
GO:0047429 | nucleoside triphosphate diphosphatase activity | 1.75% (1/57) | 6.53 | 0.010758 | 0.035861 |
GO:0008023 | transcription elongation factor complex | 1.75% (1/57) | 6.53 | 0.010758 | 0.035861 |
GO:0006368 | transcription elongation by RNA polymerase II | 1.75% (1/57) | 6.53 | 0.010758 | 0.035861 |
GO:0006354 | DNA-templated transcription elongation | 1.75% (1/57) | 6.53 | 0.010758 | 0.035861 |
GO:0004536 | DNA nuclease activity | 1.75% (1/57) | 6.36 | 0.012095 | 0.039888 |
GO:0006396 | RNA processing | 5.26% (3/57) | 2.64 | 0.012456 | 0.040645 |
GO:0006397 | mRNA processing | 3.51% (2/57) | 3.54 | 0.012879 | 0.041589 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.75% (1/57) | 6.21 | 0.01343 | 0.042483 |
GO:0071586 | CAAX-box protein processing | 1.75% (1/57) | 6.21 | 0.01343 | 0.042483 |
GO:0004519 | endonuclease activity | 3.51% (2/57) | 3.49 | 0.013858 | 0.043393 |
GO:0008079 | translation termination factor activity | 1.75% (1/57) | 6.07 | 0.014763 | 0.044869 |
GO:0006415 | translational termination | 1.75% (1/57) | 6.07 | 0.014763 | 0.044869 |
GO:0003747 | translation release factor activity | 1.75% (1/57) | 6.07 | 0.014763 | 0.044869 |
GO:0003674 | molecular_function | 57.89% (33/57) | 0.44 | 0.015062 | 0.045331 |
GO:0019856 | pyrimidine nucleobase biosynthetic process | 1.75% (1/57) | 5.95 | 0.016095 | 0.047518 |
GO:0043687 | post-translational protein modification | 5.26% (3/57) | 2.51 | 0.015979 | 0.047629 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.75% (1/57) | 5.83 | 0.017425 | 0.048663 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 1.75% (1/57) | 5.83 | 0.017425 | 0.048663 |
GO:0030880 | RNA polymerase complex | 1.75% (1/57) | 5.83 | 0.017425 | 0.048663 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 1.75% (1/57) | 5.83 | 0.017425 | 0.048663 |
GO:0005730 | nucleolus | 1.75% (1/57) | 5.83 | 0.017425 | 0.048663 |
GO:0008094 | ATP-dependent activity, acting on DNA | 3.51% (2/57) | 3.33 | 0.016979 | 0.049657 |